Creo Medical Limited
CREO.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | – | £0 | £0 |
| % Growth | – | – | 0.7% | – |
| Gross Profit | £0 | – | £0 | £0 |
| % Margin | 45.5% | – | 47.4% | 51.7% |
| EBITDA | -£0 | – | -£0 | -£0 |
| % Margin | -431.8% | – | -77.6% | -61.6% |
| Net Income | £0 | – | -£0 | -£0 |
| % Margin | 768.2% | – | -80.9% | -66.9% |
| EPS Diluted | 0.041 | – | -0.034 | -0.028 |
| % Growth | – | – | -21% | – |
| Operating Cash Flow | £0 | £0 | -£0 | -£0 |
| Capital Expenditures | £0 | £0 | -£0 | -£0 |
| Free Cash Flow | £0 | £0 | -£0 | -£0 |